REGENXBIO, Inc. (RGNX)
7.43
+0.01
(+0.13%)
USD |
NASDAQ |
Oct 02, 16:00
7.54
+0.11
(+1.48%)
After-Hours: 20:00
REGENXBIO Price : 7.43 for Oct. 2, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 02, 2026 | 7.58 | 7.62 | 7.36 | 7.43 | 1.037M |
| Oct 01, 2026 | 7.52 | 7.736 | 7.30 | 7.42 | 1.705M |
| Sep 30, 2026 | 7.49 | 7.86 | 7.35 | 7.53 | 1.789M |
| Sep 29, 2026 | 7.41 | 7.64 | 7.33 | 7.45 | 2.096M |
| Sep 28, 2026 | 7.30 | 7.495 | 7.170 | 7.47 | 1.326M |
| Sep 25, 2026 | 7.53 | 7.675 | 7.165 | 7.40 | 1.277M |
| Sep 24, 2026 | 7.45 | 7.46 | 7.12 | 7.24 | 1.516M |
| Sep 23, 2026 | 8.13 | 8.145 | 7.40 | 7.50 | 1.113M |
| Sep 22, 2026 | 8.03 | 8.25 | 7.904 | 8.15 | 1.202M |
| Sep 21, 2026 | 8.24 | 8.313 | 7.76 | 7.88 | 1.116M |
| Sep 18, 2026 | 8.22 | 8.331 | 8.00 | 8.03 | 3.375M |
| Sep 17, 2026 | 8.34 | 8.56 | 8.02 | 8.215 | 1.808M |
| Sep 16, 2026 | 7.93 | 7.99 | 7.636 | 7.98 | 1.232M |
| Sep 15, 2026 | 8.69 | 8.75 | 7.78 | 7.945 | 1.427M |
| Sep 14, 2026 | 8.58 | 8.728 | 8.49 | 8.69 | 858446.0 |
| Sep 11, 2026 | 8.69 | 8.82 | 8.39 | 8.53 | 1.029M |
| Sep 10, 2026 | 8.63 | 8.79 | 8.47 | 8.56 | 1.172M |
| Sep 09, 2026 | 8.70 | 9.025 | 8.62 | 8.73 | 1.408M |
| Sep 08, 2026 | 8.95 | 8.95 | 8.60 | 8.76 | 998960.0 |
| Sep 04, 2026 | 9.09 | 9.215 | 8.86 | 8.94 | 1.071M |
| Sep 03, 2026 | 9.56 | 9.56 | 9.00 | 9.20 | 839249.0 |
| Sep 02, 2026 | 9.34 | 9.708 | 9.20 | 9.60 | 866267.0 |
| Sep 01, 2026 | 9.38 | 9.616 | 9.28 | 9.32 | 783801.0 |
| Aug 31, 2026 | 9.50 | 9.68 | 9.09 | 9.50 | 1.612M |
| Aug 28, 2026 | 10.00 | 10.10 | 9.212 | 9.66 | 1.754M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| AbbVie, Inc. | 262.82 |
| United Therapeutics Corp. | 541.70 |
| Ardelyx, Inc. | 3.34 |
| Biomea Fusion, Inc. | 1.27 |
| RenovoRx, Inc. | 1.58 |
Price Related Metrics
| PS Ratio | 2.224 |
| PEG Ratio | -0.2121 |
| Price to Book Value | 5.608 |
| Earnings Yield | -50.94% |
| Market Cap | 402.44M |
| PEGY Ratio | -0.2121 |